Business Management

Business-in-Brief: January 2026

This month’s analytical science business news: chromatography deals, AI labs, and new instruments

  • By

  • February 6, 2026

  • 3 min

Share

Merck will acquire JSR Life Sciences' chromatography business to enhance the purification of monoclonal antibodies, with a deal expected to finalize by Q2 2026. Velaris has acquired Markes International for advancements in automated sample preparation in environmental analysis. Shimadzu is set to purchase Tescan for its expertise in electron microscopy for approximately $678 million by mid-2026. Specac has integrated Amax Precision for improved OEM manufacturing capabilities. Additionally, partnerships like the one between Thermo Fisher and NVIDIA aim to boost lab automation through AI, with several new product launches enhancing high-throughput and field performance.

Original Source(s)

Business-in-Brief: January 2026

This month’s analytical science business news: chromatography deals, AI labs, and new instruments

  • February 6, 2026

  • 3 min

Related Content

The Role of AI in Rare Disease Drug Discovery

AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies.

Overcoming the Challenges of AI Antibody Analysis

Cracking the molecular code

Scaling Science: My Precision Medicine Accessibility Mission

Sitting Down With… Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific